114 related articles for article (PubMed ID: 10938885)
1. Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech.
Baskova I; Zavalova L; Berezhnoy S; Avdonin P; Afanasjeva G; Popov E; Gabbasov Z
Platelets; 2000 Mar; 11(2):83-6. PubMed ID: 10938885
[TBL] [Abstract][Full Text] [Related]
2. Arterial antithrombotic effect of piyavit, the novel pharmacological preparation from the medicinal leech, and of its components, prostanoids and enzyme destabilase.
Baskova IP; Aguejouf OM; Azougagh-Oualane F; Zavalova LL; Basanova AV; Doutremepuich C
Thromb Res; 1995 Mar; 77(6):483-92. PubMed ID: 7624836
[TBL] [Abstract][Full Text] [Related]
3. Destabilase-lysozyme-2 - original recombinant thrombolytic preparation of medicinal leech inhibits horse platelets aggregation.
Rotkina AS; Pronina IV; Lazarev VN; Akhaev DN; Baskova IP
Patol Fiziol Eksp Ter; 2016; 60(3):47-51. PubMed ID: 29244473
[TBL] [Abstract][Full Text] [Related]
4. [Antithrombotic effect of piavit--a substance from the medicinal leech (Hirudo medicinalis), containing prostanoid and destabilase fractions].
Baskova IP; Zavalova LL; Basanova AV; Aquejouf OM; Azougagh-Oualane F; Doutremepuich C
Biokhimiia; 1995 Nov; 60(11):1775-83. PubMed ID: 8590752
[TBL] [Abstract][Full Text] [Related]
5. Destabilase, the novel epsilon-(gamma-Glu)-Lys isopeptidase with thrombolytic activity.
Baskova IP; Nikonov GI
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):167-72. PubMed ID: 1772985
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
7. Separation of monomerizing and lysozyme activities of destabilase from medicinal leech salivary gland secretion.
Baskova IP; Zavalova LL; Basanova AV; Sass AV
Biochemistry (Mosc); 2001 Dec; 66(12):1368-73. PubMed ID: 11812243
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic agents of the preparation from the medicinal leeches.
Baskova IP; Nikonov GI; Khalil S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):166-70. PubMed ID: 2459014
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
Farndale RW; Winkler AB; Martin BR; Barnes MJ
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
[TBL] [Abstract][Full Text] [Related]
10. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
11. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
May JA; Heptinstall S; Cole AT; Hawkey CJ
Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.
Herron D; Dillingham EO; Lyman BA; Zheng X; Bond SE; Salgia SR; Gollamudi R
Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):309-18. PubMed ID: 7630919
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.
Baurand A; Raboisson P; Freund M; Léon C; Cazenave JP; Bourguignon JJ; Gachet C
Eur J Pharmacol; 2001 Feb; 412(3):213-21. PubMed ID: 11166284
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
Hechler B; Magnenat S; Zighetti ML; Kassack MU; Ullmann H; Cazenave JP; Evans R; Cattaneo M; Gachet C
J Pharmacol Exp Ther; 2005 Jul; 314(1):232-43. PubMed ID: 15792995
[TBL] [Abstract][Full Text] [Related]
15. Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation.
Nunn B
Thromb Res; 1983 Sep; 31(5):657-63. PubMed ID: 6648898
[TBL] [Abstract][Full Text] [Related]
16. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Porta C; Maiolo A; Tua A; Grignani G
Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of inhibition of vascular-platelet hemostasis by salivary gland secretion of the medicinal leech Hirudo medicinalis].
Baskova IP; Nikonov GI; Mazurov AV; Missel'vits F; Leĭtin VL
Biokhimiia; 1987 Sep; 52(9):1461-8. PubMed ID: 3676359
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
19. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
Ostermann G; Till U; Thielmann K
Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
